| language |
eng
|
| Author |
Harashima Nanae
Department of Immunology, Faculty of Medicine, Shimane University, Shimane, Japan
Motoshima Takanobu
Department of Urology, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan
Komohara Yoshihiro
Department of Cell Pathology, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan
Eto Masatoshi
Department of Urology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan
|
| Subject | Anti-CTLA-4 therapy; CCL2; cyclophosphamide; IL-6; MDSC
|
| Journal Title |
CANCER SCIENCE
|
| Volume | 108
|
| Issue | 10
|
| Start Page | 1974
|
| End Page | 1984
|
| ISSN | 1347-9032
|
| ISSN（Online） | 1349-7006
|
| Published Date | 2017-10
|
| DOI | |
| PubMed ID | |
| Publisher | WILEY
|
| NII Type |
Journal Article
|
| OAI-PMH Set |
Faculty of Medicine
|
| Remark | JSPS KAKENHI, (17K07217); The Shimane University SUIGANN Project.
|
